Tandem Diabetes Care announced the commercial USA launch of the t:slim X2 Insulin Pump with Control-IQ Technology.

The Tandem t:slim X2 with Control-IQ is a hybrid closed-loop insulin delivery system. 

The Tandem t:slim X2 with Control-IQ is  first and only system cleared to deliver automatic correction boluses in addition to adjusting insulin to prevent high and low blood glucose levels. The system integrates with the Dexcom G6 CGM which requires no fingersticks for calibration or diabetes treatment decisions. The goal is to increase time in range (70-180 mg/dL) for users.

Tandem President & CEO John Sheridan stated study participants and investigators have described Control-IQ Technology as “life-changing,” “easy to use,” and “a new standard of care in insulin therapy management.”

Control-IQ Technology system:

• Adjusts insulin delivery to help prevent high and low blood glucose levels
• Automatically delivers a correction bolus
• Features Exercise and Sleep activities
• Requires zero fingersticks with using the Dexcom G6 CGM

Other variables used in this hybrid closed system are:

• insulin on board
• predicting rise and fall of blood glucose levels
• suspending basal rate if a drop in glucose level is predicted 
• increasing basal rate if elevated blood glucose levels are predicted

Individual emails are being sent out to in-warranty t:slim X2 users for possible upgrades.

Technology is moving forward with improved automation and usability which is good news for people living with diabetes.

Read more here.

Written by Catherine Cullinane RN, CDCES, our resident Tech Thursday Content Writer

---

Sign up for Diabetes Blog Bytes – we post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE!  Sign up below!

[yikes-mailchimp form=”1″]